(Q42455239)

31 October 2017

title

Resveratrol down-regulates a glutamate-induced tissue plasminogen activator via Erk and AMPK/mTOR pathways in rat primary cortical neurons (English)

1 reference

31 October 2017

7

Geon Ho Bahn

1 reference

31 October 2017

Kyu Suk Cho

1

1 reference

31 October 2017

Eun Joo Lee

2

1 reference

31 October 2017

Kyoung Ja Kwon

3

1 reference

31 October 2017

Edson Luck T Gonzales

4

1 reference

31 October 2017

Young Bin Kim

5

1 reference

31 October 2017

Jae Hoon Cheong

6

1 reference

31 October 2017

Jongmin Lee

8

1 reference

31 October 2017

Seol-Heui Han

9

1 reference

31 October 2017

Yun Tae Kim

10

1 reference

31 October 2017

Chan Young Shin

11

1 reference

31 October 2017

publication date

1 May 2014

1 reference

31 October 2017

1 reference

31 October 2017

volume

5

1 reference

31 October 2017

issue

5

1 reference

31 October 2017

page(s)

951-960

1 reference

Resveratrol and life extension.

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Anti-inflammatory effects of resveratrol and its potential use in therapy of immune-mediated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol and cellular mechanisms of cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol as a calorie restriction mimetic: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol as a therapeutic agent for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Role of resveratrol and its analogues in the treatment of neurodegenerative diseases: focus on recent discoveries

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Neuroprotective properties of resveratrol in different neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Extracellular proteolysis in the adult murine brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Experience-dependent pruning of dendritic spines in visual cortex by tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Tissue plasminogen activator and seizures: a clot-buster's secret life

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

tPA in the injured central nervous system: different scenarios starring the same actor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Transcriptional Upregulation of Plasminogen Activator Inhibitor-1 in Rat Primary Astrocytes by a Proteasomal Inhibitor MG132.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Rapid, activity-induced increase in tissue plasminogen activator is mediated by metabotropic glutamate receptor-dependent mRNA translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Key contribution of CPEB4-mediated translational control to cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Neuroprotection by resveratrol against traumatic brain injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol decreases inflammation in the brain of mice with mild traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Neuroprotective effects of resveratrol on ischemic injury mediated by modulating the release of neurotransmitter and neuromodulator in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol attenuates behavioral impairments and reduces cortical and hippocampal loss in a rat controlled cortical impact model of traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol attenuates brain damage in a rat model of focal cerebral ischemia via up-regulation of hippocampal Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Oxyresveratrol (trans-2,3',4,5'-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Inhibition of caspases and intracellular free Ca2+ concentrations are involved in resveratrol protection against apoptosis in rat primary neuron cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol ameliorates hypoxia/ischemia-induced behavioral deficits and brain injury in the neonatal rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

The role of plasminogen activators in the regulation of connective tissue metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Tissue plasminogen activator induces microglial inflammation via a noncatalytic molecular mechanism involving activation of mitogen-activated protein kinases and Akt signaling pathways and AnnexinA2 and Galectin-1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol reduces matrix metalloproteinase-2 activity induced by oxygen-glucose deprivation and reoxygenation in human cerebral microvascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of SIRT1 in human fibrosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

The neurotoxicity of tissue plasminogen activator?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4'-tri-O-acetylresveratrol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells : A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Polyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

AP-1 inhibitory peptides are neuroprotective following acute glutamate excitotoxicity in primary cortical neuronal cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

The roles of polyphenols in cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Effects of resveratrol on 12-O-tetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Impact of manganese neurotoxicity on MMP-9 production and superoxide dismutase activity in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol improves cardiomyopathy in dystrophin-deficient mice through SIRT1 protein-mediated modulation of p300 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Glucose deprivation reversibly down-regulates tissue plasminogen activator via proteasomal degradation in rat primary astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Combination treatment with VELCADE and low-dose tissue plasminogen activator provides potent neuroprotection in aged rats after embolic focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol suppresses PAI-1 gene expression in a human in vitro model of inflamed adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Masking, unmasking, and regulated polyadenylation cooperate in the translational control of a dormant mRNA in mouse oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Upstream and downstream of mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Growing roles for the mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

The mTOR pathway in the control of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Potentiation of neuronal insulin signaling and glucose uptake by resveratrol: the involvement of AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol stimulates AMP kinase activity in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol increases glutamate uptake, glutathione content, and S100B secretion in cortical astrocyte cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Protective effects of resveratrol on hydrogen peroxide induced toxicity in primary cortical astrocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3FO60397K

21 January 2018

Identifiers

DOI

10.1039/C3FO60397K

1 reference

31 October 2017

1 reference